Generex Biotechnology Corporation (NasdaqCM: GNBT) is a leader in drug delivery for metabolic diseases through the inner lining of the mouth. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth.

Generex’s flagship product, Generex Oral-lyn™, an oral insulin spray for the treatment of diabetes, is approved for sale in India, Algeria, Lebanon and Ecuador, and is in Phase III clinical trials with over 347 patients being enrolled in 74 clinical sites around the world, including sites in the United States, Canada, Bulgaria, Poland, Romania, Russia and Ukraine. Also, Generex has developed MetControl™, a proprietary Metformin medicinal chewing gum, which is currently being prepared for submission to various regulatory authorities throughout the world.

Generex’s product pipeline includes: Generex Oral-lyn™, MetControl™ Metformin Gum, Glucose RapidSpray™, BaBOOM!™ Energy Spray, Crave-NX™ Day Diet Aid Spray, Fentanyl Spray, Morphine Spray, Breast and Prostate Cancer Vaccine and Avian Influenza Vaccine.

Generex’s wholly owned subsidiary, Antigen Express, Inc., concentrates on developing proprietary vaccine formulations that work by stimulating the immune system to either attack offending agents (i.e., cancer cells, bacteria, and viruses) or to stop attacking benign elements (i.e., self proteins and allergens). Clinical development of Antigen’s synthetic peptide vaccines designed to stimulate a potent and specific immune response against tumors expressing the HER-2/neu oncogene for patients with HER-2/neu positive breast cancer in a Phase II clinical trial and patients with prostate cancer and against avian influenza in two Phase I trials. Additional development efforts includes seasonal influenza virus, H5N1, HIV, HPV, melanoma, ovarian cancer, allergy and Type I diabetes mellitus.